AzTrials
AzTrials

Apical PeriodontitisNCT06625645

Comparative Evaluation of Antimicrobial Efficacy, Clinical and Radiographic Success of Calcium Hydroxide, Chlorhexidine, and Modified Triple Antibiotic Paste in Different Combination Forms As Intracanal Medicaments Against Enterococcus Faecalis in Primary Teeth

A study testing Modified triple antibiotic paste (TAP) mixed with chlorehexidine, Modified Triple Antibiotic Paste mixed with saline and Calcium Hydroxide mixed with chlorohexidine Intracanal medication in people with Apical Periodontitis and Necrotic Primary Molars, run by Mahy Abdel Raouf Aly Kamar.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Comparing between different intracanal medications with different combination forms of Modified Triple Antibiotic Paste, Calcium Hydroxide and Chlorehexidine, regarding antimicrobial efficacy through bacterial reduction count of enterococcus Faecalis and regarding clinical and radiographic success in non vital primary… Read more about this study

Who is it for?
Ages 4 to 8 years
What is being tested?
Modified triple antibiotic paste (TAP) mixed with chlorehexidine, Modified Triple Antibiotic Paste mixed with saline and Calcium Hydroxide mixed with chlorohexidine Intracanal medication
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
No sites listed yet
Study dates
1 Jan 2025to 1 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 8 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Primary molars necessitating pulpectomy diagnosed with deep dental caries with pulp necrosis, apical periodontitis and periapical pathosis or both.
  • Non-Vital pulps.
  • Negative response to hot or cold pulp tester (ethyl chloride spray ).
  • Decayed tooth with spontaneous unprovoked long dull aching pain showing signs of necrosis of the pulp

Who cannot join

  • Medically compromised and uncooperative children
  • Tooth indicated for extraction
  • Mobile teeth (Miller's Grade 2 or more)
  • teeth with more than two-thirds of root resorption
  • previous endodontic treatment

Trial locations and contacts

No sites are listed yet.

Mahy kamar Mahy A.Raouf Kamar, Assistant Lecturer contact

01550831173

Mahy_kamar@dentistry.cu.edu.eg

About this study

Official title: Comparative Evaluation of Antimicrobial Efficacy, Clinical and Radiographic Success of Calcium Hydroxide, Chlorhexidine, and Modified Triple Antibiotic Paste in Different Combination Forms As Intracanal Medicaments Against Enterococcus Faecalis in Primary Teeth: a Randomized Clinical Trial

Comparing between different intracanal medications with different combination forms of Modified Triple Antibiotic Paste, Calcium Hydroxide and Chlorehexidine, regarding antimicrobial efficacy through bacterial reduction count of enterococcus Faecalis and regarding clinical and radiographic success in non vital primary teeth necessitating pulpectomy with follow up time 1 year.

Read the detailed description
  1. Full medical and dental history will be obtained from the parents of the patients participating in this study.
  2. A thorough clinical and radiographic examination of the tooth to be treated will be done.
  3. The tooth will be anaesthetized using the inferior alveolar nerve block technique for lower molars and infiltration for upper molars
  4. Before isolation, antisepsis of the oral cavity will be performed by rinsing for 1 min with 10 mL chlorhexidine gluconate mouth-wash 0.2 %.
  5. The tooth will be properly isolated using rubber dam.
  6. Access cavity will be performed using a round bur.
  7. The root canals will be irrigated with 1 ml sterile saline solution.
  8. Patency of the root canal will be obtained using stainless steel hand k- files size #15
  9. Working length will be determined using apex locator
  10. The first microbial samples (S1) will be collected to assess bacterial count of the root canals using 1 sterile paper point size 20, which will be inserted into the widest root canal for 1 min with pumping movements (McGurkin-Smith et al., 2005)
  11. It will be placed inside sterile tubes containing a reduced transport medium of thioglycolate.
  12. The canals will be thoroughly irrigated using 3ml syringe of 1.25% Sodium hypochlorite. A side-vented needle will be used to control the possibility of irrigant apical extrusion.
  13. Mechanical preparation will be performed with rotary system for all the cases.
  14. Irrigation with saline solution will be used to neutralize all the previously used solutions.
  15. Then, a second microbial samples (S2) representing the antibacterial effect of the mechanical preparation will be obtained with the same procedure as the first sample (S1).
  16. According to the randomization sequence, patients will be assigned to one of 4 groups:

1- A mix of modified triple Antibiotic Paste (M-TAP) and normal saline (experimental).

2- A mix of Ca(OH)2 and 2% CHX gluconate solution(experimental). 3- A mix of M-TAP and 2% CHX gluconate solution(experimental). 4- A mix of Ca(OH)2 and normal saline (control) 17) The canals will be dried and filled with intracanal medication plugged into the canal by using a plugger.

  1. At the end of the first visit a piece of sterile cotton will be placed in the pulp chamber.
  2. All teeth will be dressed with intermediate restorative material (IRM) as a temporary filling, in order to ensure proper sealing with no leakage of any oral fluids inside the root canal, which might disturb the action of the intracanal medication.
  3. After 7 days, the temporary restoration will be removed. 21) Disinfection of the operative field will take place as performed previously using the same protocol.
  4. Irrigation of the root canals with 2 mL of saline to flush out the medicaments and the third bacteriological sample (S3) will be taken out.
  5. Later, canals will be filled with Metapex (Metabiomed, Korea), followed by the placement of stainless-steel crowns (3M ESPE).
  6. The samples will be placed in sterile vials with thioglycolate (transport medium). The vials will be sealed tightly to avoid contamination and labeled. The labeled vials will be kept in a freezer and will be sent to the laboratory within 1 hour of collection, and samples will be assessed for total E. faecalis count (Qamar et al., 2023).
Being tested
Modified triple antibiotic paste (TAP) mixed with chlorehexidine, Modified Triple Antibiotic Paste mixed with saline, Calcium Hydroxide mixed with chlorohexidine Intracanal medication, calcium hydroxide mixed with saline as intracanal medication
Keywords
Necrotic Primary Teeth, Apical Periodontitis, Non Vital primary teeth, periapical pathosis of primary teeth, intracanal medication, triple antibiotic paste, enterococcus faecalis, Microbiology, bacterial reduction
Medical subject headings
Periapical Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Modified triple antibiotic paste (TAP) mixed with chlorehexidineCombination product

    M-TAP with CHX 2%

  • Modified Triple Antibiotic Paste mixed with salineCombination product

    M-TAP mixed with saline

  • Calcium Hydroxide mixed with chlorohexidine Intracanal medicationCombination product

    calcium hydroxide powder mixed with CHX 2% solution as intracanal medication

  • calcium hydroxide mixed with saline as intracanal medicationCombination product

    calcium hydroxide mixed with saline as intracanal medication for necrotic primary molars

Study groups in NCT06625645
Study groupRoleWhat they receive
Calcium Hydroxide mixed with saline as control intracanal medicationActive comparatorusing calcium hydroxide with saline as control intracanal medication for necrotic primary molars
Receives: Combination Product: calcium hydroxide mixed with saline as intracanal medication
different types and combinations of intracanal medications for necrotic primary molarsExperimentalNot described
Receives: Combination Product: Modified triple antibiotic paste (TAP) mixed with chlorehexidine; Combination Product: Modified Triple Antibiotic Paste mixed with saline; Combination Product: Calcium Hydroxide mixed with chlorohexidine Intracanal medication

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Enterococcus faecalis bacterial reduction

    Samples from canal using paper point size 20 with pumping action from the widest canal three times one after the access and gaining patency, second one after chemomechanical preparation and the third one after 7 days from intracanal medication insertion in the canal, then the samples will be placed in sterile vials with thioglycolate (transport medium). The vials will be sealed tightly to avoid contamination and labeled. The labeled vials will be kept in a freezer and will be sent to the laboratory within 1 hour of collection, and samples will be assessed for total E. faecalis count.

    Measured: 3 times, one after the access and gaining patency, second one after chemomechanical preparation and the third one after 7 days from intracanal medication insertion in the canal

Secondary outcomes (1)
  1. Clinical success

    measuring pain through presence or absence of pain Visual inspection of any changes (Redness or swelling of vestibular area (presence or absence of any change) Tenderness upon percussion ( positive or negative response) Tenderness upon touching of the vestibulum ( positive or negative response)

    Measured: 3,6 and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2024
  2. Study start1 Jan 2025 (estimated)
  3. Primary completion1 May 2025 (estimated)
  4. Study completion1 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06625645
Sponsor's protocol ID
14422023573623
Other IDs
main investigator
Status last verified
Oct 2024
First submitted
28 Sep 2024
Last updated
17 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Modified triple antibiotic paste (TAP) mixed with chlorehexidine, Modified Triple Antibiotic Paste mixed with saline and Calcium Hydroxide mixed with chlorohexidine Intracanal medication in people with Apical Periodontitis and Necrotic Primary Molars, run by Mahy Abdel Raouf Aly Kamar.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mahy kamar Mahy A.Raouf Kamar, Assistant Lecturer (01550831173, Mahy_kamar@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Enterococcus faecalis bacterial reduction (time frame: 3 times, one after the access and gaining patency, second one after chemomechanical preparation and the third one after 7 days from intracanal medication insertion in the canal). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in